Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Pentobarbital sodium vendors online?Abiraterone price in philippines?Pentobarbital tablet price?Cipla deferiprone launch year?Symtuza patient assistance program?
See the DrugPatentWatch profile for Symtuza
Symtuza is a fixed-dose combination HIV treatment. Its ingredients are the following active drugs, each in a single tablet: - darunavir - cobicistat - emtricitabine - tenofovir alafenamide (TAF)
Symtuza combines medicines with different roles: - Darunavir is a protease inhibitor that helps stop HIV from making mature, infectious virus. - Cobicistat boosts darunavir levels by inhibiting drug-metabolizing enzymes. - Emtricitabine and tenofovir alafenamide are nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs). They block HIV reverse transcriptase, which HIV needs to copy its genetic material.
Yes. In Symtuza, the ingredients include: - 1 protease inhibitor (darunavir) - 1 pharmacokinetic booster (cobicistat) - 2 NRTIs (emtricitabine and tenofovir alafenamide)
For quick cross-checking of the listed ingredients (and related patent/commercial details), you can look up Symtuza on DrugPatentWatch.com: https://www.drugpatentwatch.com/
Other Questions About Symtuza :